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Introduction
Diagnosis of alimentary disorders can be challenging in 
cats as there can be concurrence of lesions in the gastro-
intestinal tract, the liver and the pancreas. This associa-
tion was first described in 1984,1 and the term feline 
inflammatory disease (FID) was coined to describe such 
cases. Since then, this syndrome has been extensively 
characterised in the veterinary literature.2–7 Although 
the precise pathogenesis is not understood, the proxim-
ity between the liver, pancreas and duodenum might 
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Abstract
Objectives Many cats with gastrointestinal signs have coexisting abnormalities in the intestine, liver and pancreas. 
Investigations typically involve clinicopathological tests, diagnostic imaging and biopsy either at coeliotomy or by 
non-invasive means. While exploratory coeliotomy enables all organs to be sampled simultaneously, it is invasive 
and might not be necessary. The aim of the current study was to assess the performance of preliminary clinical 
information in predicting the histopathological presence of abnormalities in alimentary tract organs in cats.
Methods The records of 38 cats with alimentary tract signs, which had ultimately undergone exploratory coeliotomy 
and surgical biopsy, were reviewed. The clinical signs, clinicopathological findings, diagnostic imaging findings 
and histopathology results were reviewed.
Results On histopathological analysis, lesions were detected in 29/37 (78%) liver biopsies, in 29/35 (83%) 
gastrointestinal biopsies and in 17/37 (46%) pancreatic samples, the majority of which were inflammatory in 
nature. Clinical signs were generally poor markers of the presence of lesions in the alimentary tract. Further, while 
liver enzyme activity was relatively specific (88–100%) for detecting histopathological abnormalities in the liver, 
sensitivity was poor (11–50%). Pancreatic histopathological abnormalities were present in 1/3 of the cats with a 
positive pancreas-specific lipase result, and in 6/8 cats with a negative result. While relatively specific (57–100%) 
for both intestinal (57–100%) and hepatic (71–80%) histopathological abnormalities, abdominal ultrasonography 
lacked sensitivity for both organs (intestine 50–80%; liver 20–25%). In contrast, ultrasonography was relatively 
specific (50–80%), but not sensitive (17–22%) for detecting pancreatic lesions.
Conclusions and relevance Clinical signs, and clinicopathological and ultrasonographic abnormalities lack 
precision for hepatic and pancreatic histopathological lesions in cats with alimentary tract signs, and cannot reliably 
predict from which organs biopsies should be collected. Arguably, therefore, exploratory coeliotomy is necessary 
to determine the site of histopathological abnormalities in feline alimentary tract disorders.
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predispose,8 and it has been hypothesised that inflam-
matory lesions arise secondary to passage of enteric bac-
teria along the pancreatic and common bile ducts.
Histopathological examination of tissue samples is 
said to be the gold standard for diagnosis of FID.2,9–12 
Given the fact that lesions can be present in any or all of 
the alimentary organs, exploratory coeliotomy is argua-
bly the most appropriate method for biopsy collection, 
although its invasiveness makes it difficult to justify. As 
a result, some clinicians use data from preliminary clini-
cal investigations, namely history, physical examination, 
clinicopathological testing and diagnostic imaging, to 
decide which organs might be involved and to what 
extent. For instance, when vomiting or diarrhoea are 
observed, or when thickened intestinal loops are identi-
fied on abdominal palpation, these would prompt fur-
ther investigation of and biopsy sampling from the 
gastrointestinal tract. Similarly, the identification of 
icterus, increased liver enzyme activity, hyperbilirubi-
naemia and bilirubinuria might prompt a clinician to 
investigate and biopsy the liver, while the identification 
of abdominal pain and increased serum pancreas-spe-
cific lipase concentration might suggest the need for 
pancreatic biopsy. The findings of abdominal ultra-
sonography can also be used to identify organ-specific 
changes. In this way, preliminary clinical data are used 
to help to the clinician decide which organs to biopsy, 
whether coeliotomy is needed or whether a less invasive 
method of biopsy collection would suffice (ie, ultra-
sound-guided biopsy or gastrointestinal endoscopy). 
However, the reliability of this approach has not been 
critically assessed. The aim of the current study was to 
compare the results of preliminary clinical data with the 
results of histopathological examination in a cohort of 
suspected FID cases that ultimately had gastrointestinal, 
pancreatic and hepatic biopsies collected at exploratory 
coeliotomy.
Materials and methods
Study recruitment and eligibility criteria
The study was a retrospective, cross-sectional, cohort 
study involving cats seen at a single centre. To identify 
eligible cases, the medical records of cats referred to the 
Clinique Alliance Digestive Diseases Consultation, 
Bordeaux, France, between January 2006 and February 
2013 were reviewed. Eligibility criteria included the 
presence of signs compatible with FID (eg, anorexia, 
lethargy, vomiting, diarrhoea, icterus and weight loss), 
and having a clinical history available for review, which 
included clinical signs, routine clinicopathological 
examination, abdominal ultrasonographic examination 
and collection of hepatic, pancreatic and small intestinal 
biopsies at exploratory coeliotomy. All cats must have 
had either liver enzyme activity or abdominal ultra-
sonography, or both performed, in addition to 
histopathological assessment of at least two alimentary 
tract organs. Additional eligibility criteria included the 
absence of complete biliary tract obstruction, signs of 
encephalopathy, marked abdominal lymphadenopathy, 
or histopathological findings compatible with idiopathic 
hepatic lipidosis. Either primary or referral cases were 
eligible for inclusion. All diagnostic investigations were 
performed for the direct clinical benefit of the case, and 
owners gave written consent.
Data recording
Preliminary clinical data Information was recorded on 
signalment, clinical signs (eg, what signs were present, 
as well as duration and severity), dietary and medication 
history, and physical examination findings (eg, body 
weight, body condition score, temperature, thoracic aus-
cultation findings and abdominal palpation, as well as 
the presence of icterus, peripheral lymphadenopathy 
and dehydration).
Clinicopathological investigations The clinicopathological 
investigations used in cases included haematological 
and serum biochemical analyses, total thyroxine mea-
surement and pancreas-specific lipase assay. Haemato-
logical and serum biochemical analyses were not 
repeated if the referring veterinarian had recently per-
formed them. Total bilirubin concentration was only 
measured if the serum was visibly icteric, or if the clini-
cian requested it specifically. During the course of the 
study, haematology was performed with one of two in-
house haematology analysers (ProCyte Dx Hematology 
Analyzer [IDEXX] and LaserCyte Dx Hematology Ana-
lyzer [IDEXX]), both calibrated for feline cell morphol-
ogy. Similarly, two in-house serum biochemistry 
analysers (IDEXX VetLab Station [IDEXX] and Kbio 
4 biochemistry analyser [KITVIA]) were used. In 21 cats, 
total thyroxine concentration was measured with one of 
two in-house biochemistry analysers (SNAP Reader 
[IDEXX] and SNAPshot Dx Analyzer [IDEXX]), while 
pancreatic lipase was measured using a feline-specific 
immunoassay (feline pancreas-specific lipase, fPL Test; 
IDEXX) in 11 cats. Basic urinalysis (eg, dipstick analysis 
and measurement of specific gravity by refractometer) 
was not required for a case to be eligible for inclusion, 
but was performed in 15 cats. Faecal analysis was per-
formed in only two cats, with negative results in all, and 
these data are therefore not presented.
Abdominal ultrasonography The senior study author (VF) 
performed all abdominal ultrasonographic examinations 
using a MyLab Twice Ultrasound System (Esaote Medi-
cal SAS). Although this author is not a board-certified 
diagnostic imager, she has >15 years of experience in the 
field, and has received extensive training in ultrasonog-
raphy from board-certified diagnostic imagers. Data 
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were recorded regarding the presence of hepatic (eg, hep-
atomegaly, altered hepatic echogenicity, biliary tract dila-
tion, biliary sludge and gallbladder wall thickening), 
pancreatic (eg, altered pancreatic echogenicity and homo-
geneity), gastrointestinal (eg, increased small intestinal 
wall thickness, increased muscularis layer thickness 
[defined as being more than twice the width of the sub-
mucosa], altered intestinal wall layering and retention of 
contents within the stomach) and abdominal lymph node 
(eg, enlargement of mesenteric lymph nodes and lymph-
adenopathy [>5 mm thickness]) abnormalities.
Exploratory coeliotomy In all cases, exploratory coeliot-
omy was performed by one of three European-Board 
certified surgeons, and the name of the surgeon involved 
was recorded. The reason for surgical intervention was 
also recorded in each case and included the presence of 
lymph node thickening, distal small intestinal lesions, 
suspected cholangitis and suspected pancreatic lesions. 
In all cases, the decision to perform surgery was based 
upon preliminary clinical data and, most notably, the 
findings of ultrasonographical examination.
Histological evaluation of biopsy samples Biopsy samples 
were placed in 10% neutral buffered formalin (pH 7.4), 
and submitted to a single diagnostic pathology labora-
tory (Laboratoire d’Anatomo-Pathologie Vétérinaire du 
Sud Ouest, Toulouse, France). Samples were processed 
by routine methods for histological examination and 
examined by histopathologists working at the same 
diagnostic pathology laboratory (LAPVSO [AQ: 1]). A 
number of pathologists were involved in assessing the 
samples, although most (23/39; 59%) were conducted by 
one of three certified pathologists (FDR, Claire Dally and 
Mélanie Fine). All liver samples were scored according 
to World Small Animal Veterinary Association (WSAVA) 
Liver Standardisation Group criteria,13 while all intesti-
nal samples were scored according to the WSAVA Gas-
trointestinal Standardisation Group Criteria.14
Data handling and analysis
Data recorded from cases included signalment data, pre-
senting findings, the results of clinicopathological inves-
tigations, abdominal ultrasonography and 
histopathological examination. Data for duration of clin-
ical signs were not normally distributed (Shapiro-Wilk 
test) and are expressed as median (range); although age 
data were normally distributed, for consistency, median 
(range) is again used. Categorical data (eg, clinical signs 
and abnormalities identified with the diagnostic investi-
gations) are reported as numbers, proportions and per-
centages. A clinical sign was defined as being present 
when its presence was recorded in the medical record. 
Given that different haematological and serum biochem-
ical analysers were used throughout during the study, 
results are recorded as normal or abnormal, based upon 
the appropriate reference range for the analyser. These 
included leukocytosis (based upon an increased white 
blood cell count), anaemia (based upon decreased hae-
moglobin concentration), increased liver enzyme activ-
ity, hypoalbuminaemia, hyperbilirubinaemia and 
increased pancreas-specific lipase activity.
All data were entered into a spreadsheet (Microsoft 
Excel for Mac 2011 version 14.4.4; Microsoft Corporation), 
and statistical software (Stats Direct version 2.7.9; Stats 
Direct Ltd) was used to assist with data manipulation and 
analysis. The aim was to determine the relationship 
between key clinical findings (from history, physical 
examination, clinicopathological tests and diagnostic 
imaging) and the results of histopathological examination. 
The different clinical signs were categorised according to 
the organ most likely to be affected when that sign was 
present. Therefore, vomiting, diarrhoea and the presence 
of thickened intestinal loops on abdominal palpation were 
classified as gastrointestinal indicators, icterus was classed 
as a liver indicator and abdominal pain was classed as a 
pancreatic indicator. The different clinicopathological 
abnormalities were also classified in a similar manner, 
such that increased liver enzyme activity (alanine ami-
notransferase [ALT] and alkaline phosphatase [ALP]), 
hyperbilirubinaemia, and bilirubinuria were assumed to 
be liver indicators, and increased pancreas-specific lipase 
activity was assumed to be a pancreatic indicator. Finally, 
abnormal findings on abdominal ultrasonography were 
also used as indicators of disease in the organ affected.
We were interested in determining to what extent the 
organ indicators identified could rule disease of that 
organ either in or out. Therefore, sensitivity, specificity, 
positive predictive value (PPV) and negative predictive 
value (NPV) were calculated for each indicator for the 
presence or absence of histopathological abnormalities in 
their specific organ. For descriptive purposes, results were 
classified arbitrarily as very poor (<50%), poor (50–65%), 
moderate (66–80%) or good (>80%). Given our specific 
interest in FID, sensitivity, specificity, PPV and NPV were 
also calculated for the presence of histopathological 
changes of an inflammatory nature in the organ of inter-
est. There were two exceptions: first, for thickened intes-
tinal loops, sensitivity, specificity, PPV and NPV were 
also calculated for the presence of gastrointestinal neo-
plasia; second, for feline pancreas-specific lipase, the lim-
ited number of test results meant that it was inappropriate 
to calculate sensitivity, specificity, PPV and NPV. Instead, 
the proportions of positive and negative results with and 
without pancreatic abnormalities were reported.
In addition to this, we wished to determine whether 
the presence of an organ-specific indicator could rule out 
disease in another alimentary organ, such that targeted 
biopsy of the specific organ could then be justified. 
Therefore, for each organ indicator, we also recorded the 
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proportion (and percentage where appropriate) of cases 
with or without that indicator that had histopathological 
changes in the other organs.
Results
Study population and signalment
During the study period, a total of 258 cats were investi-
gated for possible alimentary tract disease. Of these, 38 
met the eligibility criteria for the study, including 19 pri-
mary care cases and 19 referral cases. The domestic 
shorthair breed comprised 28 (74%) of the cats in the 
study, with the remaining breeds including domestic 
longhair (n = 1;3%), Persian (n = 3; 85%), oriental (n = 5; 
13%) and Chartreux (n = 1; 3%). A total of 22 (58%) were 
neutered male and 16 (42%) were neutered female. The 
median age of the cats was 112 months (range 15–188 
months). Median duration of clinical signs before exami-
nation was 75 days (range 1–1095 days), and duration 
was classed as chronic (ie, >21 days) in 28 (73%).
Preliminary clinical findings
History and physical examination findings From the his-
tory, vomiting was present in 30 (79%) cats, and diar-
rhoea was present in 16(42%), with 24 (63%), 24 (63%) 
and 18 (47%), respectively, demonstrating anorexia, 
weight loss and lethargy. On physical examination, 
thickened intestinal loops were noted in four (11%) cats, 
with abdominal pain and icterus seen in three (8%) cats 
each. Other physical examination findings included 
dehydration (13 cats; 34%), abdominal mass lesion (three 
cats; 8%), peripheral lymphadenopathy (one cat; 3%), 
poor body condition (10 cats; 26%), and hyperthermia 
(⩾39.1 °C) (eight cats; 21%).
Clinicopathological investigations Increased ALT was 
noted in 5/35 (14%) cats, and increased ALP was seen in 
4/35 (11%) cats. Total serum bilirubin concentration was 
measured in 15 cats, and was increased in two (13%), 
while serum fPL was measured in 11 cats, and was 
increased in three (27%). Urine bilirubin was measured 
by dipstick in 15 cats, and was present in seven (47%). 
Other clinicopathological findings included leucocytosis 
(5/30; 17%), anaemia (8/31; 26%), hypoalbuminaemia 
(4/24; 17%) and proteinuria (4/15; 27%).
Ultrasonographic examination Ultrasonographic examina-
tion was performed in 37/38 cats, but one of the reports 
was inadvertently erased and data were not available for 
analysis. Thus, results were available for 36 cats, and a 
range of hepatic, pancreatic, gastrointestinal and abdom-
inal lymph node abnormalities were seen (Table 1).
Exploratory coeliotomy
There were various indications for performing explora-
tory coeliotomy in the 38 cats, with 19 (50%) having a 
single indication, 15 (39%) having two indications and 
four (10%) having three indications. Specific indica-
tions included mesenteric lymphadenopathy (20 cats; 
53%), suspected distal small intestinal lesion (19 cats; 
50%), suspected liver disease (13 cats; 34%), a suspected 
pancreatic lesion (five cats; 13%) and other reasons in 
four (11%) cats (focal peritonitis [one cat], collection of 
full-thickness biopsies to differentiate alimentary 
inflammatory bowel disease from lymphoma [one cat], 
suspected chronic pancreatitis [one cat] and reason not 
clear [one cat]).
The gross findings at coeliotomy are summarised in 
Table 2. Biopsy material was collected from the liver in 
37 cases, from the gastrointestinal tract in 35 cases and 
from the pancreas in 37 cases. Thus, all three alimentary 
organs were sampled concurrently in 31 (82%) cases, 
with two organs sampled in the remaining seven (18%) 
cats. Mesenteric lymph node was also sampled in 22 
(58%) cats, spleen in three cats and kidney in one cat 
(Table 2). Median time of hospitalisation after surgery 
was 2 days (range 1–6 days). One cat died 15 days after 
the surgery, and its final diagnosis was pancreatic neo-
plasia, while the remainder survived >15 days. There 
Table 1 Abdominal ultrasonographic findings in 36/38 
cats in the study
Organ Abnormality (n)
Liver Hepatomegaly (5)
 Hyperechoic (7)
 Hypoechoic (4)
 Heterogenous echogenicity (1)
 Biliary tract dilation (9)
 Biliary sludge (4)
 Thickened gall bladder wall (2)
 Hepatocellular nodule (2)
 Gall bladder wall nodule (1)
 Multiple hepatic cysts (1)
Pancreas Hyperechoic (1)
 Hypoechoic (2)
 Heterogenous echogenicity (9)
 Mass lesion (1)
 Cystic right lobe (1)
 Pseudocyst (1)
Gastrointestinal 
tract
Thickened small intestinal wall (11)
Thickened small intestinal muscularis 
(12) 
 Altered intestinal wall layering (1)
 Gastric retention (2)
Mesenteric lymph 
nodes
Enlarged lymph nodes >5mm (19)
Other Abdominal effusion (3)
 Splenic nodule (1)
 Accessory spleen (1)
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Table 2 Gross and histological findings after exploratory coeliotomy in 38 cats in the study
Organ Abnormality (n)
Liver  
Gross Hepatomegaly (4)
 Discolouration (19)
 Hepatocellular nodule (2)
 Cysts (1)
 Cystic mass (1)
 Liver adhered to stomach and  
pancreas (1)
 Cholecystitis (1)
Histology Fibrosis
  Mild (7)
  Moderate (2)
  Severe (0)
 Necrosis
  Mild (3)
  Moderate (0)
  Severe (0)
 Ductal hyperplasia
  Mild (3)
  Moderate (0)
  Severe (1)
 Lymphocytic cholangitis
 Chronic inflammatory cell infiltrate (eg, 
mixed cell type)
 Acute inflammatory cell infiltrate (eg, 
neutrophilic)
 Vacuolar hepatopathy
  Mild (3)
  Moderate (2)
  Severe (1)
 Lipidosis (2)
 Feline infectious peritonitis (1)
 Neoplasia
  Lymphoma (3)
  Mastocytoma (1)
Pancreas  
Gross Enlarged (3)
 Nodule (9)
Histology Fibrosis
  Mild (2)
  Moderate (0)
  Severe (1)
 Necrosis
  Mild (2)
  Moderate (0)
  Severe (0)
 Amyloid deposition (1)
 Lymphocytic-plasmacytic infiltrate
Organ Abnormality (n)
  Mild (7)
  Moderate (4)
  Severe (1)
 Nodular hyperplasia (6)
 Neoplasia
  Carcinoma (2)
  Adenoma (1)
   Pancreatic papillary intracanalicular 
tumour (1)
Gastrointestinal  
Gross Intestinal thickening
  Duodenum (4)
  Jejunum (3)
  Ileum (4)
  Colon (4)
Histology Villous stunting
  Mild (5)
  Moderate (3)
  Severe (2)
 Crypt distension
  Mild (2)
  Moderate (0)
  Severe (0)
 Lacteal dilation
  Mild (4)
  Moderate (0)
  Severe (0)
 Mucosal fibrosis
  Mild (2)
  Moderate (0)
  Severe (2)
 Epithelial injury
  Mild (3)
  Moderate (0)
  Severe (3)
 IELs [AQ: 2]
  Mild (0)
  Moderate (1)
  Severe (4)
 LP lymphocytes and  
plasma cells
  Mild (11)
  Moderate (7)
  Severe (11)
 LP neutrophils
  Mild (6)
  Moderate (1)
  Severe (1)
(Continued)
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were transient complications in a further nine cases, 
including postoperative anorexia (n = 3), postoperative 
haemorrhage (n =1), wound dehiscence (n = 1), hyper-
thermia (n = 1), hypothermia (n = 2) and hypokalae-
mia (n = 1).
Histopathological examination
Histopathological abnormalities are summarised in 
Table 2. Abnormalities were detected in 29/37 (78%) 
liver biopsies, in 29/35 (83%) gastrointestinal biopsies 
and in 17/37 (46%) pancreatic samples, the majority of 
which were inflammatory in nature (liver 20/29 [69%], 
intestine 28/29 [96%], pancreas 11/19 [58%]). 
Abnormalities were also noted in the mesenteric lymph 
node in 17/22 cases (77%), 3/4 of which 13 were inflam-
matory in nature.
Association between preliminary clinical 
information and histopathology
History and physical examination The sensitivities, speci-
ficities, PPV and NPV of a range of clinical signs for the 
presence of histopathological abnormalities within liver, 
gastrointestinal tract, and pancreas are shown in Table 3. 
Vomiting was both sensitive (81–84%) and specific 
(83–100%) for the presence of gastrointestinal abnormali-
ties, although the NPV was very poor (29%), suggesting 
absence of vomiting would not exclude gastrointestinal 
disease. Further, 21/28 (75%) and 17/28 (61%) cats with 
vomiting also had hepatic and pancreatic histopatholog-
ical abnormalities, respectively. The presence of diar-
rhoea was both very poorly sensitive (35–45%) and very 
poorly specific (11–20%) for gastrointestinal abnormali-
ties, with a correspondingly very poor NPV (6%). Fur-
ther, 14/17 (82%) and 10/17 (59%) cats with diarrhoea 
also had hepatic and pancreatic histopathological abnor-
malities, respectively. When the presence of thickened 
intestinal loops were identified, sensitivity was very 
poor (0–11%) but specificity was moderate-to-good 
(50–87%) for gastrointestinal histopathological abnor-
malities. Further, NPV was also very poor (3–14%). When 
the presence of thickened intestinal loops was used to 
determine the presence of gastrointestinal neoplasia, sen-
sitivity and PPV were very poor (both 0%), specificity 
and NPV were good (both 87%). Further, 4/4 and 1/4 
cats with thickened intestinal loops also had hepatic and 
pancreatic histopathological abnormalities, respectively.
Icterus had good specificity (94–100%) but very poor 
sensitivity (10%) for hepatic histopathological abnormal-
ities, and NPV was very poor (21–45%). Further, 3/3 and 
2/3 cats with icterus also had intestinal and pancreatic 
disease, respectively. The findings were similar for 
abdominal pain (sensitivity 9–11%, specificity 92–94%, 
NPV 48–69%). Further, all three cats with abdominal 
pain also had both intestinal and hepatic histopathologi-
cal abnormalities.
Clinical pathology The sensitivities, specificities, PPV 
and NPV of various clinicopathological tests for the 
presence of histopathological abnormalities within liver, 
gastrointestinal tract, and pancreas are shown in Table 4. 
ALT was specific for hepatic disease (88–100%), but sen-
sitivity (17–19%) and NPV (24–48%) were very poor. 
Further, 4/4 and 3/5 cats with increased ALT also had 
intestinal and pancreatic histopathological abnormali-
ties, respectively. The results for ALP were similar with 
good specificity (88–100%), but very poor sensitivity 
(11–36%) and moderate NPV (47–77%) for hepatic histo-
pathological abnormalities. Further, 3/3 and 2/4 cats 
with increased ALP also had intestinal and pancreatic 
histopathological abnormalities, respectively. When the 
results of ALT and ALP were combined (either ALT or 
ALP increased), sensitivity was good (88–100%) but 
Organ Abnormality (n)
 LP eosinophils
  Mild (2)
  Moderate (2)
  Severe (1)
 LP mixed infiltrates
  Mild (4)
  Moderate (2)
  Severe (1)
 Pyogranulomatous infiltrates (1)
 Neoplasia (6, all lymphocytic)
Mesenteric 
lymph nodes
 
Gross Enlarged hepatic lymph node (1)
 Enlarged hepatogastric lymph node (1)
 Enlarged duodenal lymph node (1)
 Enlarged jejunal lymph node (10)
 Enlarged ileocolic lymph node (4)
 Multiple lymph node enlargement (3)
Histology Inflammation (13)
 Neoplasia (4, all lymphoma)
Other  
Gross Splenic nodule
Histology Splenic hyperplastic nodule
 Feline infectious peritonitis (colon and 
liver)
 Polycystic kidney disease
 Alimentary and splenic lymphoma
 Focal peritonitis
 Mastocytoma (1: liver, spleen and lymph 
node)
LP = lamina propria
Table 2 (Continued)
Freiche et al 7
specificity was poor (22-50%), with a moderate-to-poor 
NPV (50–75%). Once again, 5/5 and 4/6 cats with 
increased ALT ± ALP also had intestinal and pancreatic 
histopathological abnormalities, respectively.
Increased serum bilirubin concentration was moder-
ately specific for hepatic histopathological abnormalities 
(67–86%), but sensitivity (7–13%) and NPV (13–46%) 
were very poor. Further, both cats with increased serum 
bilirubin concentration also had intestinal and pancre-
atic histopathological abnormalities, respectively. The 
presence of bilirubinuria was poorly sensitive (50–55%) 
and moderately specific (67%) for hepatic histopatho-
logical abnormalities, and NPV was also very poor (0–
29%). Further, 6/6 and 4/7 cats with increased 
bilirubinuria also had intestinal and pancreatic histo-
pathological abnormalities, respectively.
Serum fPL concentration Pancreatic histopathological 
abnormalities were present in 3/3 cats with a positive 
pancreas-specific lipase concentration and, in two of 
these cats, the changes were inflammatory in nature. 
However, pancreatic histopathological abnormalities 
Table 3 Performance of clinical signs for identifying abnormalities in liver, intestine and pancreas
Sign Histopathological abnormality Sensitivity Specificity PPV NPV
Vomiting  
 Gastrointestinal (any) 84 100 100 29
 Gastrointestinal (inflammation) 81  83  85 29
Diarrhoea  
 Gastrointestinal (any) 45  20  76  6
 Gastrointestinal (inflammation) 35  11  53  6
Thickened intestinal loops  
 Gastrointestinal (any) 10  50  75  3
 Gastrointestinal (inflammation) 11  80  75 14
 Gastrointestinal neoplasia  0  87   0 87
Icterus  
 Hepatic (any) 10  94  67 45
 Hepatic (inflammation) 10 100 100 21
Abdominal pain  
 Pancreatic (any) 11  94  67 48
 Pancreatic (inflammation)  9  92  33 69
NPV = negative predictive value; PPV = positive predictive value
Table 4 Performance of liver enzyme activity and abdominal ultrasonography for identifying abnormalities in liver, 
intestine and pancreas
Test Histopathological 
abnormality
Sensitivity (%) Specificity (%) PPV NPV
ALT  
 Hepatic (any) 17  88  60 48
 Hepatic (inflammation) 19 100 100 24
ALP  
 Hepatic (any) 11  88  50 47
 Hepatic (inflammation) 36 100 100 77
ALT ± ALP  
 Hepatic (any) 22  88  67 50
 Hepatic (inflammation) 50 100 100 75
Serum bilirubin  
 Hepatic (any) 13  86  50 46
 Hepatic (inflammation)  7  67  50 13
Urine bilirubin  
 Hepatic (any) 50 n/a  86 29
 Hepatic (inflammation) 55  67 100  0
ALP = alkaline phosphatase; ALT = alanine aminotransferase; NPV = negative predictive value; PPV = positive predictive value; n/a = result 
could not be calculated because none of the cats without bilirubinuria had normal hepatic histopathology
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were also present in 3/8 cats with a negative fPL concen-
tration, and the changes were of an inflammatory type in 
two cases. Further, all three of the cats with increased 
serum fPL concentration also had intestinal and hepatic 
histopathological abnormalities.
Ultrasonography The sensitivity and specificity of ultra-
sonography for the presence of histopathological abnor-
malities of liver, gastrointestinal tract and pancreas are 
shown in Table 5. Both sensitivity (50–80%) and specific-
ity (57–100%) were moderate for the presence of gastroin-
testinal histopathological abnormalities. For lesions in 
the liver, ultrasonographic examination was moderately 
specific (71–80%), but sensitivity was very poor (20–25%). 
When the association between ultrasonographic findings 
and the presence of inflammatory pancreatic lesions was 
assessed, the sensitivity was moderate (80%), but speci-
ficity was very poor (22%). Results were worse for pan-
creatic neoplasia with poor sensitivity (50%) and very 
poor specificity (17%).
Discussion
The current study has assessed the ability of preliminary 
clinical data to identify alimentary tract disease, based 
on the presence of histopathological abnormalities on 
biopsy samples collected at coeliotomy. As previously 
reported,2,15,16 a range of histopathological abnormalities 
was identified in all alimentary tract organs, but the 
association with the presence of clinical signs, clinico-
pathological abnormalities and abdominal ultrasono-
graphic findings was poor. These results call into 
question the use of preliminary clinical data in decision 
making, namely in determining the most appropriate 
sites of the alimentary tract to sample. They further sug-
gest that, unless all alimentary tract organs are sampled 
at exploratory coeliotomy, the full extent of pathological 
abnormalities might be missed.
The cats in the current study presented with a range 
of clinical signs that gave little clue as to the ultimate site 
of abnormalities. Vomiting was most common clinical 
sign, as previously described for feline inflammatory 
bowel disease,7 and while both sensitive and specific for 
histopathological abnormalities in the gastrointestinal 
tract, the NPV was poor, suggesting the absence of vom-
iting could not be used to eliminate the possibility of 
gastrointestinal disease. This clinical sign was assigned 
to the gastrointestinal category; it was recognised that 
many other non-gastrointestinal diseases can cause 
vomiting, including those of the pancreas and liver.7 
Diarrhoea is a second sign that is often used to indicate 
intestinal disease, and was again used in the current 
study as a gastrointestinal indicator. However, sensitiv-
ity, specificity and NPV were all poor, suggesting that 
veterinarians should not use the presence or absence of 
diarrhoea to decide whether or not to biopsy the gastro-
intestinal tract. Further, given that a significant number 
of cats with diarrhoea also had histopathological abnor-
malities, the presence of diarrhoea cannot be used to 
exclude disease in other alimentary organs. Apparent 
thickening of intestinal loops was an uncommon abdom-
inal palpation finding in the current study, being present 
in only 4/38 cats. Although it might be assumed that this 
sign would correlate with infiltrative disease, none of 
these cases had gastrointestinal neoplasia. Therefore, 
this is a non-specific finding, and should be interpreted 
cautiously.
Arguably, icterus is a more specific clinical sign as, 
once haemolysis is eliminated as a cause, the abnormal-
ity is likely to reflect either hepatic or posthepatic dis-
ease. As a result, this clinical sign was chosen as a liver 
indicator in the current study. However, although all 
cases with icterus were ultimately found to have histo-
pathological abnormalities within their liver, this finding 
was uncommon (three cats), and the majority (90%) of 
Table 5 Performance of abdominal ultrasonography for identifying abnormalities in liver, intestine and pancreas
Organ Histopathological abnormality Sensitivity (%) Specificity (%) PPV NPV
Intestine  
 Any abnormality 50 100 100 11
 Inflammation 50  67  88 22
 Neoplasia 80  57  24 94
Liver  
 Any abnormality 24  80  88 15
 Inflammation 20  71  50 38
 Neoplasia 25  77  13 88
Pancreas  
 Any abnormality 78  20  54 43
 Inflammation 80  22  31 71
 Neoplasia 50  17   8 71
NPV = negative predictive value; PPV = positive predictive value
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those with liver disease were not icteric. Therefore, 
unfortunately, this clinical sign cannot be relied upon to 
identify all cases where a liver biopsy would be fruitful. 
Further, the fact that cats with icterus also had disease in 
other alimentary organs suggests that it cannot be used 
as a basis for not sampling other alimentary tract organs. 
However, while this sign performed poorly as a liver 
indicator, it is partly explained by the fact that cases with 
biliary tract obstruction and idiopathic hepatic lipidosis 
were excluded. Further studies would be required to 
assess performance of icterus in identifying such disor-
ders. Abdominal pain was used as a pancreatic indicator 
but, as with icterus, it was only observed in three cases. 
In fact, only two of these cases actually had pancreatic 
histopathological abnormalities, while there were a fur-
ther 17 cats with pancreatic disease that did not have 
abdominal pain. Thus, as noted in previous studies,17 
abdominal pain is uncommon in cats with pancreatic 
disease, and should not be used in decision making for 
cases with suspected alimentary tract disease.
Liver enzymes are specific markers of hepatic disease 
in cats and, given the short half lives relative to other 
species, any abnormality is thought to be significant.18 
However, in a recent study, liver enzyme activity in cats 
was a poor predictor of the severity of inflammation in 
cats with cholangitis.5 Similarly, in the current study, 
despite the fact that approximately three-quarters of cats 
had histopathological evidence of liver disease, increased 
liver enzyme activity was seen in only a minority. While 
specificity was good, sensitivity and NPV were both 
poor. Findings were equivalent for hyperbilirubinaemia, 
and worse for bilirubinuria. This suggests that, even 
when clinicopathological indicators of liver disease are 
normal, hepatic pathological abnormalities cannot be 
ruled out. Therefore, it would not be advisable for a cli-
nician to use such results to decide against either per-
forming exploratory coeliotomy or hepatic biopsy.
Measurement of pancreas-specific lipase is now com-
monplace in cats with alimentary tract signs, and previ-
ous studies have suggested reasonable sensitivity and 
specificity.18,19 The results of the current study did not 
indicate that this assay performed any better than other 
preliminary clinical data. However, one limitation was 
the fact that, given that most cases were chronic and, 
pancreas-specific lipase activity was only assessed in 11 
cats. Thus, firm conclusions on test performance should 
be made with caution, and future studies should be con-
sidered to address this issue.
Like liver enzyme activity, hepatic ultrasonography is 
also commonly used to identify the presence of liver dis-
ease, and to determine the need for biopsy. Indeed, sensi-
tivity (87%) and specificity (90%) are reportedly good for 
identifying cats with cholangitis,20 with increased echo-
genicity being a common feature.21 In contrast, although 
the current study suggested that ultrasonography was 
relatively specific (71–80%), it was poorly sensitive (20–25%) 
for detecting hepatic abnormalities. Operator effect might 
be one explanation for the difference in results between 
studies and one potential limitation of the current work 
was the fact that board-certified diagnostic imagers did 
not perform the investigations. Any adverse effect on 
performance would be partly offset by the fact that only 
one operator performed all examinations, who had 
received extensive training in abdominal diagnostic 
imaging and used one machine. A second possible reason 
for the difference in results is the type of cases studied, 
with the current study including a wide population of 
cats with alimentary tract signs, rather than those that 
just had hepatic disease. Whatever the reason, the authors 
would recommend caution with using abdominal ultra-
sonography to determine whether or not to perform 
hepatic biopsy. Caution is also advised when using ultra-
sonography to detect gastrointestinal lesions, where per-
formance was even worse than with hepatic abnormalities. 
Further studies assessing the use of ultrasonography for 
alimentary tract disease would help to clarify the circum-
stances where this modality is of greatest benefit.
Previous studies have examined the use of ultra-
sonography to detect pancreatic disease in cats,22,23 and 
both sensitivity and specificity are reported to be moder-
ately good.23 In contrast, the findings of the current study 
suggest that for ultrasonography, while sensitivity was 
moderately good (78%) for detecting pancreatic inflam-
mation, specificity was poor (22%). The reasons why 
these results contrast with those of previous studies are 
not known but might again be explained by operator 
effect and differences in the case population examined. 
More concerning was the fact that, in four cats, a pancre-
atic tumour was identified after pancreatic biopsy, three 
of which were malignant, but these had been missed on 
ultrasonography. Therefore, once again, caution is advis-
able when using ultrasonography as a screening test in 
feline alimentary tract disease, and the authors suggest 
that pancreatic biopsy is a necessary step when investi-
gating feline alimentary tract disorders.
Exploratory coeliotomy is an invasive procedure 
compared with other biopsy techniques, and many clini-
cians and owners are reluctant to undertake it. In the 
current study, the most common reasons for performing 
an exploratory coeliotomy, in about half of all cats, were 
the identification of enlarged mesenteric lymph nodes 
and suspicion of a distal gastrointestinal lesion on 
abdominal ultrasonographic examination. In other stud-
ies, lymph node enlargement is an important finding,24,25 
and can suggest the presence of lymphoma.7 In contrast, 
the main reason for using coeliotomy when a distal small 
intestinal lesion was suspected was the relative inacces-
sibility of this region for sampling by a less invasive 
method such as endoscopy. Unlike lymph node enlarge-
ment and distal small intestinal lesions, suspected 
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hepatic and pancreatic lesions were less commonly used 
as the reason for performing coeliotomy. Despite its per-
ceived invasiveness, mean duration of hospitalisation 
after surgery was brief (ie, <2 days) and, where compli-
cations were seen, they were typically mild and tran-
sient. One serious complication previously described is 
leakage of luminal contents from the site of surgical inci-
sion,26 but this was not seen in the current study. Further, 
no cases of postoperative pancreatitis were reported, 
despite the frequent collection of biopsies from this 
organ. Thus, the findings of the current study would 
suggest that exploratory coeliotomy is relatively safe 
and well tolerated. Nonetheless, given the small group 
size and the fact that the procedures were conducted at a 
specialist centre, the findings might not be fully repre-
sentative of cats from primary care practice. Therefore, 
clinicians should discuss possible complications with 
the owner before the procedure, so that this can form the 
basis for deciding how to proceed in any specific case.
The study has a number of limitations, many of which 
are inherent in its retrospective design. First, there was 
no control group for comparison, for instance cats with-
out confirmed gastrointestinal disease, in order to com-
pare test performance in cats with and without 
alimentary disease. Second, given that the study was 
conducted over 7 years, different analysers were used 
for the clinicopathological analysers. As methods and 
reference ranges were different, it was not possible to 
look at data in a quantitative manner. Instead, results 
were interpreted on the basis of whether or not they 
were normal or abnormal. Third, gamma glutamyl trans-
ferase was not measured, and this might have improved 
the performance of liver enzyme activity in identifying 
hepatic histopathological abnormalities. Fourth, because 
exploratory coeliotomy is considered to be invasive, 
only a limited number (ie, up to three) full-thickness 
small intestinal biopsies were collected and thus gastro-
intestinal histopathological findings might not have 
been completely representative. In a similar manner, 
when sampling the pancreas and liver, only one biopsy 
sample was taken from each organ. Thus, the relatively 
poor associations between the clinicopathological and 
ultrasonographical findings and histopathological 
lesions might be related to the fact that genuine lesions 
were missed if patchy disease was present. For instance, 
a previous necropsy study revealed that chronic inflam-
mation is more common in the left pancreatic lobe than 
in the right lobe.27 Although biopsy samples were usu-
ally taken from the left lobe of the pancreas in the current 
study, the fact that the right lobe was rarely sampled 
might still have produced some false negative results 
and, once again, only one full-thickness hepatic biopsy 
was collected. Thus, the findings might not have been 
totally representative of the global degree of inflamma-
tion involving those organs.
A fifth limitation was the fact that histopathological 
assessments were performed by a number of different 
pathologists, which might have resulted in inconsisten-
cies in interpretations. Finally, perhaps the most impor-
tant issue was the fact that only a small cohort of cats 
was examined from a referral clinic. Cats were only 
included if an exploratory coeliotomy had been per-
formed, which would likely have skewed case selection. 
It is possible that the very reason that the clinician 
selected coeliotomy, and not a non-invasive procedure, 
was the fact that the case was more complicated, and this 
might have inadvertently selected for cases where pre-
liminary clinical data were equivocal. Finally, while we 
have reported positive and predictive values, these are 
highly dependent on the true prevalence of disease in 
the population assessed. Thus, our results are only 
meaningful relative to the population sampled, and 
might not be representative of other populations. Most 
notably, the study population was from a referral clinic, 
and thus affected by selection bias (ie, because they are 
more likely to be severe, difficult or complex cases); 
therefore, the predictive values might not be representa-
tive of what would be expected in primary care practice. 
Thus, it would be sensible to consider further studies to 
confirm or refute the current study findings.
Conclusions
As previously reported, it is common for cats presenting 
with gastrointestinal signs to have histopathological 
abnormalities in a number of organs concurrently. 
Preliminary clinical data, including signs, clinicopatho-
logical results and ultrasonography, lack precision and 
cannot reliably predict from which organs biopsy mate-
rial should be collected. Given the fact that exploratory 
coeliotomy is generally well tolerated, the authors would 
recommend this as the procedure of choice for diagnosis 
of feline gastrointestinal diseases.
Acknowledgements The authors would like to thank Dr 
P. Maître and S. Bureau, of the Clinique Alliance. Bordeaux, 
France, who performed the surgical procedures. The authors 
would also like to thank the pathologists at LAPVSO, and espe-
cially F. Degorce-Rubiales for performing histopathological 
examination.
Conflicts of interest AJG’s readership is financially sup-
ported by Royal Canin.
Funding This research received no specific grant from any fund-
ing agency in the public, commercial or not-for-profit sectors.
References
 1 Zawie DA and Garvey MS. Feline hepatic disease. Vet Clin 
North Am Small Anim Pract 1984; 14: 1201–1230.
 2 Weiss DJ, Gagne JM and Armstrong PJ. Relationship 
between inflammatory hepatic disease and inflammatory 
Freiche et al 11
bowel disease, pancreatitis, and nephritis in cats. J Am Vet 
Med Assoc 1996; 209: 1114–1116.
 3 Mansfield CS and Jones BR. Review of feline pancreatitis 
part one: the normal feline pancreas, the pathophysiol-
ogy, classification, prevalence and aetiologies of pancre-
atitis. J Feline Med Surg 2001; 3: 117–124.
 4 Brain PH, Barrs VR, Martin P, et al. Feline cholecystitis and 
acute neutrophilic cholangitis: clinical findings, bacterial 
isolates and response to treatment in six cases. J Feline Med 
Surg 2006; 8: 91–103.
 5 Callahan Clark JE, Haddad JL, Brown DC, et  al. Feline 
cholangitis: a necropsy study of 44 cats (1986–2008). J 
Feline Med Surg 2011; 13: 570–576.
 6 Gieger T. Alimentary lymphoma in cats and dogs. Vet Clin 
North Am Small Anim Pract 2011; 41: 419–432.
 7 Jergens AE. Feline idiopathic inflammatory bowel dis-
ease: what we know and what remains to be unraveled. J 
Feline Med Surg 2012; 14: 445–448.
 8 Lapointe J.M, Higgins R, Barrete N, et al. Enterocccus hirae 
enteropathy with ascending cholangitis and pancreatitis 
in a kitten. Vet Pathol 2000; 37: 282–284.
 9 Xenoulis PG and Steiner JM. Current concepts in feline 
pancreatitis. Top Companion Anim Med 2008; 23: 185–192.
 10 Webb CB and Trott C. Laparoscopic diagnosis of pancre-
atic disease in dogs and cats. J Vet Intern Med 2008; 22: 
1263–1266.
 11 Cosford KL, Shmon CL, Myers SLL, et al. Prospective eval-
uation of laparoscopic pancreatic biopsies in 11 healthy 
cats. J Vet Intern Med 2010; 24: 104–113.
 12 Warren A, Center S, McDonough S, et al. Histopathologic 
features, immunophenotyping, clonality, and eubacterial 
fluorescence in situ hybridization in cats with lymphocytic 
cholangitis/cholangiohepatitis. Vet Pathol 2011; 48: 627–641.
 13 Van den Ingh TSGAM, Cullen JM, Twedt DC, et al. Mor-
phological classification of biliary disorders of the canine 
and feline liver. In: Rothuizen J, Bunch SE,  Charles JA, et al. 
(eds). WSAVA standards for clinical and histological diag-
nosis of canine and feline liver diseases. WSAVA Liver Stan-
dardization group. Amsterdam: Elsevier, 2006, pp 61–76.
 14 Day MJ, Biltzer T, Mansel J, et  al. World Small Animal 
Veterinary Association Gastrointestinal Standardization 
group. Histopathological standards for the diagnosis of 
gastrointestinal inflammation in endoscopic biopsy sam-
ples from the dog and cat: a report from the World Small 
Veterinary Association Gastrointestinal Standardization 
Group. J Comp Pathol 2008; 138(Suppl. 1): S1–S43
 15 Gagne JM, Armstrong PJ, Weiss DJ, et al. Clinical features 
of inflammatory liver disease in cats: 41 cases (1983–1993). 
J Am Vet Med Assoc 1999; 214: 513–516.
 16 Kleinschmidt S, Harder J, Nolte I, et al. Chronic inflamma-
tory and non-inflammatory diseases of the gastrointesti-
nal tract in cats: diagnostic advantages of full-thickness 
intestinal and extraintestinal biopsies. J Feline Med Surg 
2009; 12: 97–103.
 17 Armstrong PJ and Williams DA. Pancreatitis in cats. Top 
Companion Anim Med 2012; 27: 140–147.
 18 Hecht S and Henry G. Sonographic evaluation of the nor-
mal and abnormal pancreas. Clin Tech Small Anim Pract 
2007; 22: 115–121.
 19 Forman MA, Marks SL, De Cock HE, et al. Evaluation of 
serum feline pancreatic lipase immunoreactivity and heli-
cal computed tomography versus conventional testing for 
the diagnosis of feline pancreatitis. J Vet Intern Med 2004; 
18: 807–815.
 20 Marolf AJ, Leach L, Gibbons DS, et  al. Ultrasonographic 
findings of feline cholangitis. J Am Anim Hosp Assoc 2012; 
48: 36–42.
 21 Washabau RJ. Liver. In: Washabau RJ and Day MJ (eds). 
Canine and feline gastroenterology. St Louis, MO: Elsevier 
Saunders, 2012, pp 849–957.
 22 Newell SM, Selcer BA, Girard E, et al. Correlations between 
ultrasonographic findings and specific hepatic diseases 
in cats: 72 cases (1985–1997). J Am Vet Med Assoc 1998; 213: 
94–98.
 23 Ruaux CG. Diagnostic approaches to acute pancreatitis. 
Clin Tech Small Anim Pract 2003 184: 245–249.
 24 Besso J, Rault D and Begon D. Feline caecum and ileocolic 
junction: normal ultrasonographic features and clinical 
applications [abstract]. Vet Radiol Ultrasound 2004; 45: 599.
 25 Taeymans O, Holt N, Penninck DG, et al. Ultrasonographic 
characterization of feline ileocolic abnormalities. Vet 
Radiol Ultrasound 2011; 52: 335–339.
 26 Ellison GW. Complications of gastrointestinal surgery in 
companion animals. Vet Clin North Am Small Anim Pract 
2011; 41: 915–934
 27 De Cock HE, Forman MA, Farver TB, et al. Prevalence and 
histopathologic characteristics of pancreatitis in cats. Vet 
Pathol 2007; 44: 39–49.
